Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. J Neurol Sci. 2011 Apr 15; 303(1-2):109-13.
View in:
PubMed
subject areas
Adult
Age of Onset
Aged
Cohort Studies
Data Interpretation, Statistical
Disability Evaluation
Disease Progression
Female
Humans
Immunosuppressive Agents
Interferon Type I
Interferon-beta
Longitudinal Studies
Male
Middle Aged
Models, Statistical
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Peptides
Predictive Value of Tests
Prognosis
Prospective Studies
Recombinant Proteins
Sex Characteristics
Treatment Outcome
Young Adult
authors with profiles
Rohit Bakshi, M.D.
Howard Lee Weiner, M.D.
Tanuja Chitnis, M.D.
Brian Curran Healy, Ph.D.